Meta-analysis of effect of nintedanib on mortality in subjects with idiopathic pulmonary fibrosis (IPF) and other forms of progressive pulmonary fibrosis ( PPF)

被引：0
|
作者：
Wuyts, Wim A. [1 ]
Maher, Toby M. [2 ]
Wijsenbeek, Marlies [3 ]
Koschel, Dirk [4 ]
Martinez, Fernando J. [5 ]
Stansen, Wibke [6 ]
Stowasser, Susanne [7 ]
Richeldi, Luca [8 ]
机构：
[1] Univ Hosp Leuven, Dept Pulm Med, Unit Interstitial Lung Dis, Leuven, Belgium
[2] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
[3] Univ Med Ctr, Dept Resp Med, Erasmus MC, Rotterdam, Netherlands
[4] Fachkrankenhaus Coswig, Coswig, Germany
[5] Weill Cornell Med, New York, NY USA
[6] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany
[7] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[8] Univ Cattolica Sacro Cuore, Fdn Policlin Gemelli IRCCS, Rome, Italy
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA2875
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Effect Of Nintedanib On Disease Progression In The Inpulsis® Trials In Patients With Idiopathic Pulmonary Fibrosis (ipf)
    Raghu, G.
    Inoue, Y.
    Behr, J.
    Cottin, V.
    Stowasser, S.
    Stansen, W.
    Maher, T. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [22] Predictors of Mortality in Patients with Idiopathic Pulmonary Fibrosis (IPF)
    du Bois, R.
    Albera, C.
    Bradford, W.
    Costabel, U.
    Hormel, P.
    King, T., Jr.
    Noble, P.
    Szwarcberg, J.
    Thomeer, M.
    Valeyre, D.
    Weycker, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [23] Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis: Preliminary Results of a Systematic Review and Meta-analysis
    Teoh, A. K.
    Glenn, L. M.
    Corte, T. J.
    Holland, A. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [24] Systematic Review and Meta-analysis of Pirfenidone, Nintedanib, and Pamrevlumab for the Treatment of Idiopathic Pulmonary Fibrosis
    Di Martino, Enrica
    Provenzani, Alessio
    Vitulo, Patrizio
    Polidori, Piera
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (06) : 723 - 731
  • [25] COMBINATION THERAPY WITH PIRFENIDONE AND NINTEDANIB IN IDIOPATHIC PULMONARY FIBROSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Gandhi, Tanmay
    Shah, Aniruddh
    Saluja, Prachi
    Kocurek, Emily
    CHEST, 2023, 164 (04) : 3027A - 3027A
  • [26] Smoking and Idiopathic Pulmonary Fibrosis: A Meta-analysis
    Fang, Min
    He, Bixiu
    Xiao, Jian
    NICOTINE & TOBACCO RESEARCH, 2024, 26 (12) : 1599 - 1606
  • [27] Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis
    Zheng, Qiang
    Cox, Ingrid A.
    Campbell, Julie A.
    Xia, Qing
    Otahal, Petr
    de Graaff, Barbara
    Corte, Tamera J.
    Teoh, Alan K. Y.
    Walters, E. Haydn
    Palmer, Andrew J.
    ERJ OPEN RESEARCH, 2022, 8 (01)
  • [28] Nintedanib for the Idiopathic Pulmonary Fibrosis with Emphysema
    Krome, Susanne
    PNEUMOLOGIE, 2019, 73 (03):
  • [29] Nintedanib for the treatment of idiopathic pulmonary fibrosis
    Varone, Francesco
    Sgalla, Giacomo
    Iovene, Bruno
    Bruni, Teresa
    Richeldi, Luca
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (02) : 167 - 175
  • [30] Changes in biomarkers in patients with idiopathic pulmonary fibrosis (IPF) treated with nintedanib and sildenafil
    White, Eric
    Crestani, Bruno
    Guenther, Andreas
    Maher, Toby M.
    Ittrich, Carina
    Diefenbach, Claudia
    Rohr, Klaus B.
    Quaresma, Manuel
    Kolb, Martin
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
12345